CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD

被引：3
|
作者：
Edwards, David K.
Javidi-Sharifi, Nathalie
Rofelty, Angela
Gordon, Max
Roth-Carter, Riley
Tardi, Paul
Mayer, Lawrence
Tyner, Jeffrey W.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1087
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation
    Edwards, David K.
    Javidi-Sharifi, Nathalie
    Rofelty, Angela
    Rosenfeld, Claire
    Roth-Carter, Riley
    Tardi, Paul
    Mayer, Lawrence
    Tyner, Jeffrey W.
    BLOOD, 2016, 128 (22)
  • [2] Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML
    Melgar, Katelyn
    Walker, MacKenzie
    Jiang, Jian-kang
    Wilson, Kelli
    Mulloy, James C.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    BLOOD, 2015, 126 (23)
  • [3] Developing dual FLT3/MNK inhibitors to overcome sorafenib resistance in FLT3-ITD AML cells
    Zhao, Linxiang
    Zuo, Shuwei
    Xing, Kun
    Yue, Xiaoshuang
    Zhang, Huimin
    Zhang, Jingyi
    Waxman, Samuel
    Jing, Yongkui
    CANCER RESEARCH, 2024, 84 (06)
  • [4] CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation
    Gordon, Max J.
    Tardi, Paul
    Loriaux, Marc M.
    Spurgeon, Stephen E.
    Traer, Elie
    Kovacsovics, Tibor
    Mayer, Lawrence D.
    Tyner, Jeffrey W.
    LEUKEMIA RESEARCH, 2017, 53 : 39 - 49
  • [5] Role of HDAC8 Upregulation in Resistance of FLT3-ITD AML Stem Cells to FLT3 Inhibitors
    Long, Jun
    Jia, Mingyuan
    Fang, Weiyue
    Chen, Xinjie
    Wang, Zhongyu
    Mu, Lili
    Xiang, Rufang
    Li, Jun-Min
    Hong, Dengli
    Liang, Aibin
    Hu, Jiong
    BLOOD, 2019, 134
  • [6] Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant
    Bazarbachi, Abdul Hamid
    Al Hamed, Rama
    Malard, Florent
    Mohty, Mohamad
    Bazarbachi, Ali
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [7] FLT3 Inhibitors in Mutant FLT3 AML
    Stone, Richard M.
    Garcia, Jacqueline
    ANNALS OF HEMATOLOGY, 2017, 96 : S36 - S37
  • [8] FLT3-ITD negative relapse following FLT3 inhibition
    Mullen, Christopher
    Campbell, Victoria
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 84 - 84
  • [9] Dual Inhibition of AKT/FLT3-ITD by A674563 Overcomes FLT3 Ligand-Induced Drug Resistance in FLT3-ITD positive AML
    Wang, Aoli
    Wu, Hong
    Chen, Cheng
    Hu, Chen
    Qi, Ziping
    Wang, Wenchao
    Yu, Kailin
    Liu, Xiaochuan
    Zou, Fengming
    Zhao, Zheng
    Wu, Jiaxin
    Liu, Juan
    Liu, Feiyang
    Wang, Li
    Stone, Richard M.
    Galinksy, Ilene A.
    Griffin, James D.
    Zhang, Shanchun
    Weisberg, Ellen L.
    Liu, Jing
    Liu, Qingsong
    ONCOTARGET, 2016, 7 (20) : 29131 - 29142
  • [10] Role of Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Yan, Chengcheng
    Paterson, Andrew J.
    Li, Hui
    Anderson, Nick
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Yang, Jing
    Xie, Min
    Lu, Rui
    Welner, Rob S.
    Bhatia, Ravi
    BLOOD, 2019, 134
12345